Patent · US Active

Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof

US9486492B2 · kind B2 · utility

0Cited by

22References

9Claims

0Family size

Assignee

University of South Florida · US

Inventors

Jin Q. Cheng · Tampa, US
Said M. Sebti · Tampa, US

Key dates

Filing date	Oct 19, 2015
Grant date	Nov 8, 2016
Priority date	—
Expiry date	Oct 19, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application relates to combination therapies including triciribine and related compounds and bortezomib and derivatives thereof analogs and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.